Marija G.
- Country
- Croatia
- Department
- Oncology Clinic, Department of Urogenital Tumors
Research Overview
- Phase 3 Randomized Study of Perioperative Enfortumab Vedotin and Pembrolizumab Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-Eligible Muscle-Invasive Bladder Cancer
- An Open-label, Randomized Phase 3 Study to Evaluate Efficacy and Safety of Pembrolizumab (MK-3475) in Combination with Belzutifan (MK-6482) and Lenvatinib (MK-7902), or MK-1308A in Combination with Lenvatinib, versus Pembrolizumab and Lenvatinib, as First-line Treatment in Participants with Advanced Clear Cell Renal Cell Carcinoma (ccRCC)
- Phase 3 Randomized Open-label Study of Belzutifan and Zanzalintinib Versus Cabozantinib in Advanced Renal Cell Carcinoma Post Anti-PD-1/L1 Therapy
Data & Insights
Has run more than one trial at 41 of 155 partner sites.
Specializations
Multiple Sclerosis and Neuroimmunology
Clinical research activity includes relapsing and progressive forms of multiple sclerosis, with attention to long-term disease control, relapse prevention, and treatment persistence in inflammatory central nervous system disorders.
- Relapsing forms of multiple sclerosis
- Progressive multiple sclerosis
- Neuroinflammatory disease
Additional involvement extends to therapies for focal seizures and other neurological conditions linked to chronic immune-mediated dysfunction.
Inflammatory Bowel Disease
Research interests cover Crohn’s disease and ulcerative colitis, including moderate to severe disease requiring advanced anti-inflammatory and immunomodulatory treatment strategies.
- Crohn’s disease
- Ulcerative colitis
- Intestinal inflammation
The therapeutic focus also includes maintenance of remission and management of chronic gastrointestinal immune disease.
Oncology and Hematologic Malignancies
Clinical trial involvement spans solid tumors and blood cancers, with emphasis on treatment options for advanced, relapsed, or refractory disease across multiple malignant conditions.
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
- Breast cancer
Research activity also includes multiple myeloma, myeloproliferative neoplasms, renal cell carcinoma, melanoma, and non-small cell lung cancer.
Cardiovascular, Thrombotic, and Lipid Disorders
Areas of interest include prevention and treatment of atherosclerotic cardiovascular disease, atrial fibrillation, heart failure, and ischemic stroke, together with disorders of coagulation and lipid metabolism.
- Atherosclerotic cardiovascular disease
- Heart failure
- Haemophilia
Related work also covers hyperlipidaemia, thromboembolic risk, and major adverse cardiovascular events.
Autoimmune, Dermatologic, and Rare Disease Therapies
Research engagement includes immune-mediated and rare conditions such as atopic dermatitis, hidradenitis suppurativa, bullous pemphigoid, epidermolysis bullosa, and Sjögren’s syndrome.
- Atopic dermatitis
- Hidradenitis suppurativa
- Rare autoimmune and genetic skin disease
Additional therapeutic interests include kidney disease, amyloidosis, and other chronic immune-mediated disorders.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.